Kalaris Announces Upcoming Presentation of TH103 Phase 1a Clinical Data at American Society of Retina Specialists; Ph 1b/2 Clinical Trial Actively Enrolling

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/8/2026

1. IONQ
2. SPY
3. AAPL
4. ACN
5. IONS
6. AZN
7. ROIV
8. HOOD
9. QCOM
10. NVDA

Go back to Kalaris Announces Upcoming Presentation of TH103 Phase 1a Clinical Data at American Society of Retina Specialists; Ph 1b/2 Clinical Trial Actively Enrolling
(NASDAQ: KLRS) Delayed: 3.80 -0.1 (2.56%)
Previous Close $3.90    52 Week High $ 
Open $3.88    52 Week Low $ 
Day High $3.90    P/E N/A 
Day Low $3.80    EPS $ 
Volume 30,815